Modulating vaccine responses with dendritic cells and Toll-like receptors.
about
The Global HIV/AIDS Vaccine Enterprise: scientific strategic planDEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesSystems biology in vaccine designCD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive VaccinesIn vitro atrazine exposure affects the phenotypic and functional maturation of dendritic cellsProtective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesChoreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organsToll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets.Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.In situ photoimmunotherapy: a tumour-directed treatment for melanoma.HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.Transdermal influenza immunization with vaccine-coated microneedle arrays.Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skinEnhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunityAdvances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsCombinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategyDifferential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.Antiviral activity of ginseng extract against respiratory syncytial virus infectionCD8+ memory T-cell inflation renders compromised CD4+ T-cell-dependent CD8+ T-cell immunity via naïve T-cell anergy.Generation of T cell responses targeting the reactive metabolite of halothane in mice.Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis.Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.Modulation of adaptive immunity with Toll-like receptorsCationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system.Memory CD4+ T cells induce innate responses independently of pathogen.HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.Constitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-κB ligand (RANK)-L by rat plasmacytoid dendritic cells.HIV vaccine trial exploits a dual and central role for innate immunity.Strategies to use immune modulators in therapeutic vaccines against cancerTLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation.Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example.Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.Mucosal adjuvant properties of the Shigella invasin complexCritical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.Dendritic cell control of tolerogenic responses.
P2860
Q21563445-03BFD7DF-2B0C-4FA2-A16A-F417FFC5A0D2Q24682603-36495EE0-FC89-40F9-8876-E0409025E3F3Q26851326-EEDA56A7-5EC5-42FF-B0D4-1169EA55343BQ27014949-846F678B-8248-48EB-A13E-B89BFF4B0FFAQ27481382-1C953FA1-0616-41BA-A2EA-CC1920136182Q30390753-5795BE09-47B0-4C20-9307-AAB9F89BE721Q30489790-C0DEC77A-9AF3-430D-A6CF-18C66DD5C6D1Q30834266-97D6D55C-5C69-4BCB-B5AD-C883A3F41CDAQ30973875-B7828FF2-50B0-4AFE-90E7-4D69651ACD0FQ33263668-5309B918-5A67-4D68-A7E9-945F3B6C6966Q33305012-F6441FE4-B13B-4C4B-A580-AD9D3829A40CQ33332129-46056AC7-94A4-458C-A5AB-B629F9232890Q33416417-1F83E4AE-DD5F-45A8-8156-D262D8BCBEC9Q33506637-5C55D5BE-155B-42B2-B152-7C7872369CFCQ33557050-8248FE50-35D7-4B19-BAD8-D4A0C1B3DD2AQ33609436-29D33B62-A866-4C93-A4CD-60A100792F86Q33653495-95A1EB45-9CF7-4EC2-B1A0-126BB05DD7BFQ33721641-4A80F64B-817D-4A79-B18D-2B09132B5791Q33746872-F2AD032F-0285-4EEA-A976-77C8744A94B3Q33749309-3D9FC5E0-5D43-46E0-B391-F00A35023A9AQ33784386-248924DE-0D1E-4574-9D17-4E44EA072013Q33811236-984C8691-7B24-4749-9D1D-05ABF0C4537BQ33820931-EFFE54E2-AD3C-4F32-A51D-54DC181FE4DEQ33835976-71AE2877-7D23-421D-B21D-BCC8774C2731Q33922778-B668252D-2E3A-44C8-8C8C-573231C23F76Q33959068-3E536378-3274-4397-A9D8-EBDCABF1E046Q33996621-6DD5F834-CF78-420D-B6C8-F3B8F8535257Q34016666-06638042-DF44-4181-9A97-B0EE838C0B79Q34034287-68E72A80-6448-4DCE-9A60-1FDC67D841F3Q34081189-6EE2355A-16E0-40C3-8D99-EE019ED7289AQ34085119-11D1217D-4035-4760-BA3F-0D9262D7F759Q34201118-1C08F6CE-6D94-40F4-9C47-2BE1C06AD993Q34261579-A9419A0F-73C1-40FA-899D-77303CE268DBQ34275601-DC5E1B6E-0CD2-477C-94CE-6019A6030D00Q34289268-2B8D4DD9-B182-44B7-947D-4F8A5275DB80Q34396165-9EF063DE-F1E6-4F9B-AC4F-57191E72C1A3Q34448382-EEFF8055-6C21-480E-A655-948A103CD240Q34601845-A7DF9A02-A3F1-4D83-B7D9-834224B1A3BFQ34712969-05037BF1-BE03-4C6A-930E-04992F594D28Q34982085-4F077BC5-7755-409D-8E5B-47BAFF21811F
P2860
Modulating vaccine responses with dendritic cells and Toll-like receptors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@ast
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@en
type
label
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@ast
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@en
prefLabel
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@ast
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@en
P2860
P1476
Modulating vaccine responses with dendritic cells and Toll-like receptors.
@en
P2093
Bali Pulendran
P2860
P304
P356
10.1111/J.0105-2896.2004.00144.X
P577
2004-06-01T00:00:00Z